Choose your location:

Choose a Language

Contact us
May 3, 2022

Combined Shareholders’ Meeting of 24 May 2022

This article or press release has no online content. Please download the associated documents for more information.

Associated Documents

Documents-availability-2022-Ipsen-Combined-Shareholders-Meeting.pdf
Convening-notice-–-2022-Ipsen-Combined-Shareholders-Meeting.pdf
Voting-form-–-2022-Ipsen-Combined-Shareholders-Meeting.pdf
Ipsen-voting-rights-on-15-April-2022-–-2021-Ipsen-Combined-Shareholders-Meeting.pdf
Auditors-report-on-the-resolutions-submitted-to-the-2022-Shareholders-Meeting-AGA.pdf

News Center

View all

Understanding the true impact of living with FOP

News

Ipsen Announces Decision to Permanently Discontinue Distribution of NutropinAq® (somatropin) cartridges

News

Applications now open for the 2023 Golden Ticket Competition

News

Offering support to those impacted in Turkey & Syria

News
© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023